Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Rationale: Idiopathic pulmonary fibrosis (IPF) involves the accumulation of α-smooth muscle actin–expressing myofibroblasts arising from interactions with soluble mediators such as transforming growth factor-β1 (TGF-β1) and mechanical influences such as local tissue stiffness. Whereas IPF fibroblasts are enriched for aerobic glycolysis and innate immune receptor activation, innate immune ligands related to mitochondrial injury, such as extracellular mitochondrial DNA (mtDNA), have not been identified in IPF. Objectives: We aimed to define an association between mtDNA and fibroblast responses in IPF. Methods: We evaluated the response of normal human lung fibroblasts (NHLFs) to stimulation with mtDNA and determined whether the glycolytic reprogramming that occurs in response to TGF-β1 stimulation and direct contact with stiff substrates, and spontaneously in IPF fibroblasts, is associated with excessive levels of mtDNA. We measured mtDNA concentrations in bronchoalveolar lavage (BAL) from subjects with and without IPF, as well as in plasma samples from two longitudinal IPF cohorts and demographically matched control subjects. Measurements and Main Results: Exposure to mtDNA augments α-smooth muscle actin expression in NHLFs. The metabolic changes in NHLFs that are induced by interactions with TGF-β1 or stiff hydrogels are accompanied by the accumulation of extracellular mtDNA. These findings replicate the spontaneous phenotype of IPF fibroblasts. mtDNA concentrations are increased in IPF BAL and plasma, and in the latter compartment, they display robust associations with disease progression and reduced event-free survival. Conclusions: These findings demonstrate a previously unrecognized and highly novel connection between metabolic reprogramming, mtDNA, fibroblast activation, and clinical outcomes that provides new insight into IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, normal human lung fibroblasts treated with isolated mtDNA expressed high levels of α-smooth muscle actin, which is a characteristic of fibrotic disease, suggesting that mtDNA plays a role in the pathophysiology of IPF (Ryu et al., 2017).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Ryu et al., 2017
In the citing paper
“Elevated concentration of mtDNA was also found in plasma and bronchoalveolar lavage from patients with idiopathic pulmonary fibrosis (IPF) (Ryu et al., 2017).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Ryu et al., 2017
In the citing paper
“The level of plasma mtDNA was associated with disease progression and was shown to predict mortality (Ryu et al., 2017).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Ryu et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial DNA induces inflammation and increases TLR9/NF-κB expression in lung tissue
ZHANG, J.-Z., LIU, Z., LIU, J., REN, J.-X., & SUN, T.-S. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1650 · Cited by 194
RetractedRaghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
Self-citationNakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Gustafsson, M. G. L., Shao, L., Carlton, P. M., Wang, C. J. R., Golubovskaya, I. N., Cande, W. Z., Agard, D. A., & Sedat, J. W. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120345 · Cited by 1,557
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Tomassetti, S., Lee, J. S., Poletti, V., Buccioli, M., Elicker, B. M., Jones, K. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00004 · Cited by 1,308 · cited 1×
“5 years (2), it predominately affects individuals aged 60–75 years old (3) and exhibits a highly variable disease course (4) that would benefit from prognostic models incorporating clinical parameters with circulating biomarkers (5, 6).”
BackgroundAlpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity
Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G., & Chaponnier, C. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.9.2730 · Cited by 1,288 · cited 1×
“Because stiffness-induced a-SMA expression is known to be at least partially TGF-b1 dependent (52), our work suggests that changes in mitochondrial function could occur via a similar mechanism through additional mechanotransductive signaling pathways, such as Rho-associated kinase 1, YAP/TAZ, and Hippo (11).”
BackgroundMitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps
Yousefi, S., Mihalache, C., Kozlowski, E., Schmid, I., & Simon, H. U. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.96 · Cited by 1,036
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
Liu, F., Mih, J. D., Shea, B. S., Kho, A. T., Sharif, A. S., Tager, A. M., & Tschumperlin, D. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004082 · Cited by 810 · cited 2×
“In our study, culture of otherwise normal lung fibroblasts on hydrogels approximating the stiffness of the fibrotic lung that have previously been shown to induce a-SMA expression (31, 50) led to substantial increases in the detection of extracellular mtDNA.”
BackgroundThe Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 679 · cited 1×
“However, because TGF-b1’s pleiotropic functions make therapeutic targeting difficult (10), interruption of its downstream effects may be both safer and more efficacious.”
BackgroundAcellular Normal and Fibrotic Human Lung Matrices as a Culture System for In Vitro Investigation
Booth, A. J., Hadley, R., Cornett, A. M., Dreffs, A. A., Matthes, S. A., Tsui, J. L., Weiss, K., Horowitz, J. C., Fiore, V. F., Barker, T. H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0754oc · Cited by 665 · cited 1×
“In our study, culture of otherwise normal lung fibroblasts on hydrogels approximating the stiffness of the fibrotic lung that have previously been shown to induce a-SMA expression (31, 50) led to substantial increases in the detection of extracellular mtDNA.”
BackgroundPINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627 · cited 2×
“Immunohistochemistry-based detection of TOM20 in IPF lung tissue revealed the previously reported expression in alveolar epithelial cells and macrophages (32) and also in a-SMA–expressing cells located in areas of fibrosis (Figures 5A and 5B).”
BackgroundSelf-citationNoth, I., Zhang, Y., Ma, S.-F., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 614 · cited 1×
“Innate immune cells such as macrophages are believed to amplify fibrosis via a variety of mechanisms (11); mutations in genes related to innate immunity are associated with IPF (12), and expression of innate immune receptors such as Toll-like receptor 9 (TLR9) (13) demonstrate outcomepredictive properties in IPF (14).”
BackgroundSelf-citationGlycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0780oc · Cited by 582 · cited 3×
“0004) (Figure 4B) that have previously been reported for these cells (9, 27).”
BackgroundHepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498 · cited 4×
“DNA Isolation and Quantification Isolation and quantification of the human MT-ATP6 gene and/or ACTB from fibroblasts, Escherichia coli, cell-free culture supernatants, BAL fluid, and plasma were performed as previously described (17, 22).”
BackgroundMethodInfluentialSelf-citationNakahira, K., Kyung, S.-Y., Rogers, A. J., Gazourian, L., Youn, S., Massaro, A. F., Quintana, C., Osorio, J. C., Wang, Z., Zhao, Y., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001577 · Cited by 445 · cited 3×
“DNA Isolation and Quantification Isolation and quantification of the human MT-ATP6 gene and/or ACTB from fibroblasts, Escherichia coli, cell-free culture supernatants, BAL fluid, and plasma were performed as previously described (17, 22).”
BackgroundMethodAnimal Models of Fibrotic Lung Disease
B. Moore, B., Lawson, W. E., Oury, T. D., Sisson, T. H., Raghavendran, K., & Hogaboam, C. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0094tr · Cited by 412 · cited 1×
“A characteristic feature of IPF is the accumulation of a-smooth muscle actin (a-SMA)–expressing myofibroblasts (1) that may arise from normal lung fibroblasts in response to biochemical influences such as transforming growth factor-b1 (TGF-b1) (1) and biophysical responses to the stiffened microenvironment (7).”
BackgroundNeutrophil extracellular traps promote differentiation and function of fibroblasts
Chrysanthopoulou, A., Mitroulis, I., Apostolidou, E., Arelaki, S., Mikroulis, D., Konstantinidis, T., Sivridis, E., Koffa, M., Giatromanolaki, A., Boumpas, D. T., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4359 · Cited by 404 · cited 1×
“Exposure to mtDNA (18) or synthetic analogs (14) is sufficient to activate macrophages and fibroblasts in several experimental settings, including experimentally induced lung fibrosis (18), and mtDNA participates in the formation of neutrophil extracellular traps that contribute to inflammation and tissue remodeling i…”
BackgroundCytometric assessment of mitochondria using fluorescent probes
Cottet‐Rousselle, C., Ronot, X., Leverve, X., & Mayol, J. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21061 · Cited by 399
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0058oc · Cited by 381 · cited 1×
“5 years (2), it predominately affects individuals aged 60–75 years old (3) and exhibits a highly variable disease course (4) that would benefit from prognostic models incorporating clinical parameters with circulating biomarkers (5, 6).”
BackgroundSelf-citationHerazo-Maya, J. D., Noth, I., Duncan, S. R., Kim, S., Ma, S.-F., Tseng, G. C., Feingold, E., Juan-Guardela, B. M., Richards, T. J., Lussier, Y., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005964 · Cited by 325 · cited 1×
“5 years (2), it predominately affects individuals aged 60–75 years old (3) and exhibits a highly variable disease course (4) that would benefit from prognostic models incorporating clinical parameters with circulating biomarkers (5, 6).”
BackgroundSelf-citationNeutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?
Porto, B. N., & Stein, R. T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00311 · Cited by 317
Mitochondrial DNA nucleoid structure
Bogenhagen, D. F. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.11.005 · Cited by 290 · cited 1×
“By 7 days, evaluation of mitochondrial substructure by structured illumination microscopy–based immunofluorescence of the mitochondrial outer membrane marker TOM20 and the major mtDNA packaging protein mitochondrial transcription factor A showed that, in contrast to unstimulated cells, which displayed the typical find…”
BackgroundSelf-citationZhou, B., Liu, Y., Kahn, M., Ann, D. K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276311 · Cited by 261
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236 · cited 3×
“A characteristic feature of IPF is the accumulation of a-smooth muscle actin (a-SMA)–expressing myofibroblasts (1) that may arise from normal lung fibroblasts in response to biochemical influences such as transforming growth factor-b1 (TGF-b1) (1) and biophysical responses to the stiffened microenvironment (7).”
BackgroundSelf-citationZhou, Y., Peng, H., Sun, H., Peng, X., Tang, C., Gan, Y., Chen, X., Mathur, A., Hu, B., Slade, M. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007096 · Cited by 215
Self-citationMitochondria released by cells undergoing TNF-α-induced necroptosis act as danger signals
Maeda, A., & Fadeel, B. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.277 · Cited by 201 · cited 1×
“One such ligand is the hypomethylated, CpG-rich mitochondrial DNA (mtDNA) that is released by both necrotic cells (16) and viable cells in response to various stressors (17).”
BackgroundHerzog, E. L., Mathur, A., Tager, A. M., Feghali‐Bostwick, C., Schneider, F., & Varga, J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38702 · Cited by 193
Self-citationMolecular biomarkers in idiopathic pulmonary fibrosis
Ley, B., Brown, K. K., & Collard, H. R. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2014 · Cited by 172
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Trujillo, G., Meneghin, A., Flaherty, K. R., Sholl, L. M., Myers, J. L., Kazerooni, E. A., Gross, B. H., Oak, S. R., Coelho, A. L., Evanoff, H., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001510 · Cited by 160 · cited 3×
“We have not determined whether plasma mtDNA stems from intact mitochondria present in circulating exosomes, whether this DNA is oxidized as has recently been shown for nonalcoholic steatohepatitis (17), or whether these findings are directly related to the TLR9 activation that has been proposed as a contributor to poo…”
BackgroundSelf-citationInvolvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis
Kobayashi, K., Araya, J., Minagawa, S., Hara, H., Saito, N., Kadota, T., Sato, N., Yoshida, M., Tsubouchi, K., Kurita, Y., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600265 · Cited by 145 · cited 1×
“Interestingly, despite the distinct alterations in fibroblast metabolism caused by TGF-b1 (8, 9), as well as the demonstration of mitochondrial abnormalities as a driver of myofibroblast activation and experimentally induced lung fibrosis (20), an association of IPF with the extracellular accumulation of mtDNA has not…”
BackgroundSanjuan, M. A., Rao, N., Lai, K.-T. A., Gu, Y., Sun, S., Fuchs, A., Fung-Leung, W.-P., Colonna, M., & Karlsson, L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508058 · Cited by 132
Negmadjanov, U., Godic, Z., Rizvi, F., Emelyanova, L. V., Ross, G. R., Richards, J. O., Holmuhamedov, E., & Jahangir, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123046 · Cited by 121 · cited 2×
“TGF-b1 also critically regulates the alterations in mitochondrial function and bioenergetics that are required to fuel these activated cells (8, 9).”
BackgroundMatrix Biology of Idiopathic Pulmonary Fibrosis
Thannickal, V. J., Henke, C. A., Horowitz, J. C., Noble, P. W., Roman, J., Sime, P. J., Zhou, Y., Wells, R. G., White, E. S., & Tschumperlin, D. J. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.02.003 · Cited by 117 · cited 3×
“Innate immune cells such as macrophages are believed to amplify fibrosis via a variety of mechanisms (11); mutations in genes related to innate immunity are associated with IPF (12), and expression of innate immune receptors such as Toll-like receptor 9 (TLR9) (13) demonstrate outcomepredictive properties in IPF (14).”
BackgroundMethodJulian, M. W., Shao, G., Bao, S., Knoell, D. L., Papenfuss, T. L., VanGundy, Z. C., & Crouser, E. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101375 · Cited by 112
Toll-like Receptor 9 Can be Activated by Endogenous Mitochondrial DNA to Induce Podocyte Apoptosis
Bao, W., Xia, H., Liang, Y., Ye, Y., Lu, Y., Xu, X., Duan, A., He, J., Chen, Z., Wu, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22579 · Cited by 111
TLR9 and the Recognition of Self and Non‐Self Nucleic Acids
LAMPHIER, M. S., SIROIS, C. M., VERMA, A., GOLENBOCK, D. T., & LATZ, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.005 · Cited by 106
Ley, B., Bradford, W. Z., Vittinghoff, E., Weycker, D., du Bois, R. M., & Collard, H. R. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1546oc · Cited by 106 · cited 1×
“Additional investigations relating mtDNA to clinical predictors of mortality and FVC percent predicted decline, which is currently difficult to predict on the basis of clinical factors alone (53), might improve disease stratification in IPF.”
BackgroundGu, X., Wu, G., Yao, Y., Zeng, J., Shi, D., Lv, T., Luo, L., & Song, Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.034 · Cited by 87 · cited 3×
“mtDNA Stimulation Induces a-SMA Expression in NHLFs A variety of immune and stromal cells can internalize and respond to CpG-rich DNA (14, 18, 30).”
BackgroundMatrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast Phenotype
Southern, B. D., Grove, L. M., Rahaman, S. O., Abraham, S., Scheraga, R. G., Niese, K. A., Sun, H., Herzog, E. L., Liu, F., Tschumperlin, D. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712380 · Cited by 85 · cited 1×
“Cellular responses to local tissue stiffness are believed to drive the fibroblast activation in a variety of settings, including IPF (49).”
BackgroundSelf-citationChen, J.-F., Liu, H., Ni, H.-F., Lv, L.-L., Zhang, M.-H., Zhang, A.-H., Tang, R.-N., Chen, P.-S., & Liu, B.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083593 · Cited by 76 · cited 1×
“pyridone derivative that improves mitochondrial function in experimentally induced injury models (35) and enacts modest stabilizing effects on ventilatory decline as well as, potentially, survival in a subset of patients with IPF (1).”
BackgroundMitochondrial DNA and Toll-Like Receptor-9 Are Associated With Mortality in Critically Ill Patients
Krychtiuk, K. A., Ruhittel, S., Hohensinner, P. J., Koller, L., Kaun, C., Lenz, M., Bauer, B., Wutzlhofer, L., Draxler, D. F., Maurer, G., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001311 · Cited by 75 · cited 1×
“Furthermore, although elevations in circulating mtDNA predict mortality in several clinical settings (21, 22), a clinical relationship with IPF outcomes has yet to be defined.”
BackgroundFluctuation-driven mechanotransduction regulates mitochondrial-network structure and function
Bartolák‐Suki, E., Imsirovic, J., Parameswaran, H., Wellman, T. J., Martínez, N., Allen, P. G., Frey, U., & Suki, B. (2015) · Nature Materials · doi:10.1038/nmat4358 · Cited by 74 · cited 1×
“Although cultured endothelial cells subject to cyclical stress demonstrate degraded mitochondrial integrity (51), to our knowledge, ours are the first data demonstrating a direct link between the biophysical aspects of the lung microenvironment and metabolic remodeling in fibroblasts.”
BackgroundDanger-Associated Molecular Patterns and Danger Signals in Idiopathic Pulmonary Fibrosis
Ellson, C. D., Dunmore, R., Hogaboam, C. M., Sleeman, M. A., & Murray, L. A. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0366tr · Cited by 72
The effects of DNA containing CpG motif on dendritic cells
Behboudi, S., Chao, D., Klenerman, P., & Austyn, J. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00979.x · Cited by 68 · cited 2×
“mtDNA Stimulation Induces a-SMA Expression in NHLFs A variety of immune and stromal cells can internalize and respond to CpG-rich DNA (14, 18, 30).”
BackgroundDNA recognition in immunity and disease
Holm, C. K., Paludan, S. R., & Fitzgerald, K. A. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.006 · Cited by 64
Sun, H., Zhu, Y., Pan, H., Chen, X., Balestrini, J. L., Lam, T. T., Kanyo, J. E., Eichmann, A., Gulati, M., Fares, W. H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39575 · Cited by 61 · cited 2×
“Thus, NHLFs were cultured for 7 days on tunable hydrogels constructed to approximate the mean stiffness of the normal (1 kPa) and fibrotic (20 kPa) human lung (26).”
BackgroundMethodSelf-citationSustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts
Kirillov, V., Siler, J. T., Ramadass, M., Ge, L., Davis, J. E., Grant, G. M., Nathan, S. D., Járai, G., & Trujillo, G. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.011 · Cited by 52 · cited 4×
“Culture and TGF-b1 Stimulation of Human Lung Fibroblasts NHLFs and IPF fibroblasts obtained from Lonza (Allendale, NJ) and Asterand Bioscience (Detroit, MI) were used between passages 3 and 7 and stimulated with and without 5 ng/ml of recombinant human TGF-b1 as previously described (14).”
BackgroundMethodInfluentialSelf-citationSample preparation for single molecule localization microscopy
Allen, J. R., Ross, S. T., & Davidson, M. W. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp53719f · Cited by 43
Bronchoalveolar Lavage in Idiopathic Interstitial Lung Diseases
Nagai, S., Handa, T., Ito, I., Takeuchi, M., & Izumi, T. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-991522 · Cited by 38 · cited 1×
“differences in recovery with BAL samples obtained from healthy subjects versus those with fibrotic lung disease, multiple studies have demonstrated the useful role of BAL in IPF (33), and we accepted it as an additional surrogate of the IPF lung microenvironment.”
BackgroundUnderstanding TLR9 action in Epstein-Barr virus infection
Zauner, L., & Nadal, D. (2011) · Frontiers in bioscience · doi:10.2741/3982 · Cited by 33
Research works printed but not linked: 2
- Ryu, 2017, Mitochondrial DNA is released from lung fibroblasts in response to the fibrotic lung microenvironment and is predictive of mortality in idiopathic pulmonary fibrosis [abstract], Am J Respir Crit Care Med, 195, A6917
- Xie, 2015, Glycolytic Reprogramming in myofibroblast differentiation and lung fibrosis, Am J Respir Crit Care Med, 192, 1462, 10.1164/rccm.201504-0780oc · DOI · Paper page
Cited by
Mitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 602
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Ornatowski, W., Lu, Q., Yegambaram, M., Garcia, A. E., Zemskov, E. A., Maltepe, E., Fineman, J. R., Wang, T., & Black, S. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101679 · Cited by 467
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 351
“This association has been confirmed in a mice model of bleomycin-induced lung fibrosis, where macrophages metabolic reprogramming shifts glycolysis to FAO [171, 174].”
BackgroundThyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function
Yu, G., Tzouvelekis, A., Wang, R., Herazo-Maya, J. D., Ibarra, G. H., Srivastava, A., de Castro, J. P. W., DeIuliis, G., Ahangari, F., Woolard, T., et al. (2018) · Nature Medicine · doi:10.1038/nm.4447 · Cited by 356
“Recently, there has been significant interest in mitochondrial function in chronic lung diseases 9,11,32 .”
Self-citationThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“Inflammasome activation in IPF may also occur via toll-like receptor 9 (TLR9) as detection of this PRR (85) and its endogenous ligand mitochondrial DNA are both increased in IPF (86).”
BackgroundSelf-citation
Metadata
- Authors
- Ryu, C., Sun, H., Gulati, M., Herazo-Maya, J. D., Chen, Y., Osafo-Addo, A., Brandsdorfer, C., Winkler, J., Blaul, C., Faunce, J., Pan, H., Woolard, T., Tzouvelekis, A., Antin-Ozerkis, D. E., Puchalski, J. T., Slade, M., Gonzalez, A. L., Bogenhagen, D. F., Kirillov, V., Feghali-Bostwick, C., Gibson, K., Lindell, K., Herzog, R. I., Dela Cruz, C. S., Mehal, W., Kaminski, N., Herzog, E. L., & Trujillo, G.
- Affiliations
- Section of Pulmonary, Critical Care, and Sleep Medicine
- Yale University (US)
- Department of Pharmacology and
- Stony Brook School (US)
- Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; and
- University of Pittsburgh Medical Center (US)
- Section of Endocrinology and Metabolism, and
- Corresponding author
- Trujillo, Glenda
- ORCID
- Ryu, Changwan
- Sun, Huanxing
- Gulati, Mridu
- Chen, Yonglin
- Winkler, Julia
- Pan, Hongyi
- Tzouvelekis, Argyrios
- Puchalski, Jonathan T.
- Slade, Martin
- Gonzalez, Anjelica L.
- Bogenhagen, Daniel F.
- Kirillov, Varvara
- Gibson, Kevin
- Lindell, Kathleen
- Herzog, Raimund I.
- Mehal, Wajahat
- Kaminski, Naftali
- Herzog, Erica L.
- Trujillo, Glenda
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-12
- Volume
- 196
- Issue
- 12
- Pages
- 1571-1581
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5754440
- OpenAlex
- W2745223933
- Cited by
- 171
- References
- 55
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 15 · 2023: 26 · 2022: 12 · 2021: 21 · 2020: 28 · 2019: 23 · 2018: 19 · 2017: 3
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX003259)
- Ellison Medical Foundation
- European Respiratory Society
- Greenfield Foundation
- European Commission
- Stony Brook University
- National Institutes of Health (UL1TR000005, 5r01hl125850-04, UL1-TR- 000005, HL125850, DK045735, AR061271, UL1TR001863, 1s10od016405-01)
- National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
- National Heart, Lung, and Blood Institute (R01HL126094, R01-HL-125850, U01HL112702, T32HL007778, K08HL103770, R01HL109233, U01HL122626, UH3HL123886, R01HL127349)
- National Institute of General Medical Sciences (R01GM112790)
- National Institute of Diabetes and Digestive and Kidney Diseases (R56DK076674, R01DK101984, P30DK045735)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR061271, K24AR060297)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, lung fibroblasts, myofibroblast activation, alpha-smooth muscle actin, TGF-β1, tissue stiffness, aerobic glycolysis, metabolic reprogramming, innate immune response, bronchoalveolar lavage, plasma biomarkers, disease progression, mortality prediction
- MeSH terms
- Aged, DNA, Mitochondrial, Female, Fibroblasts, Humans, Male, Disease-Free Survival, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.